copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
FINTEPLA® (fenfluramine) | Official Patient Website FINTEPLA is a prescription medicine used to treat seizures associated with Dravet syndrome and Lennox-Gastaut syndrome in patients 2 years of age and older It is not known if FINTEPLA is safe and effective in children less than 2 years of age
Fenfluramine - Epilepsy Foundation Fenfluramine is the generic name (non-brand name) of a seizure medicine with the brand name Fintepla® from Zogenix
Fintepla (fenfluramine): Uses, Side Effects, Dosage Reviews Fintepla (fenfluramine) is an antiepileptic (antiseizure) medication that's used for people ages 2 years and older This medication is only meant for those with seizures caused by Dravet syndrome or Lennox-Gastaut syndrome, not other seizure conditions Fintepla (fenfluramine) comes as an oral solution, so it's a good option for people who can't swallow pills
Fintepla® | UCB Fintepla® | UCBIn the European Union and in the UK, Fintepla ® is indicated for the treatment of seizures associated with Dravet syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older
Fintepla (fenfluramine) - Uses, Side Effects, and More Overview: Fintepla is used to treat certain types of seizures It may work by blocking certain signals that come from nerves and cause seizures Common side effects include weight loss, sleepiness
Fintepla (FenfluramineOral Solution): Side Effects, Uses . . . What Is Fintepla? Fintepla (fenfluramine) is an anticonvulsant used to treat seizures associated with Dravet syndrome in patients 2 years of age and older What Are Side Effects of Fintepla? Fintepla may cause serious side effects including: hives, difficulty breathing, swelling of your face, lips, tongue, or throat, mood or behavior changes
FDA Approves New Therapy for Dravet Syndrome | FDA FDA approves Fintepla (fenfluramine), a Schedule IV controlled substance, for the treatment of seizures associated with Dravet syndrome in patients age 2 and older Dravet syndrome is a life